Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.4.a^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.4.b^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.4.c^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.4.d^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.4.e^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.4.f^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.4.g^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.5.a^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.5.b^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.5.c^3
Pieper M et al. (2012)
|
Xla Wt + gata2 MO
NF16 (in situ hybridization)
|
|
|